34.46000 USD
1.05
3.14%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
32.75
35.15500
Previous close
33.41000
Open
33.80000
Access this stock data via API
Subscribe
Lyell Immunopharma, Inc.
34.46
1.05
3.14%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 15K 8K 7K 11K
Cost of revenue
Gross profit
Operating expense
Research & development 28.2M 34.9M 43.4M 48.7M
Selling general and admin 10.7M 9.8M 14.0M 14.5M
Other operating expenses -1.6M 1.1M -119K -513K
Operating income -37.3M -45.7M -57.4M -62.7M
Non operating interest income
Income 3.3M 3.3M 3.9M 4.9M
Expense
Other income expense -4.9M -263K 1.3M -134.2M
Pretax income -38.8M -42.7M -52.2M -191.9M
Tax provision
Net income -38.8M -42.7M -52.2M -191.9M
Basic EPS -2.1 -2.9 -3.6 -13.0
Diluted EPS -2.1 -2.9 -3.6 -13.0
Basic average shares 18.3M 14.8M 14.8M 14.7M
Diluted average shares 18.3M 14.8M 14.8M 14.7M
EBITDA -34.7M -41.1M -53.9M 80.8M
Net income from continuing op. -38.8M -42.7M -52.2M -191.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 6 hours

21:59
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).